ethamsylate has been researched along with Respiratory Distress Syndrome, Newborn in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amato, M; Hüppi, PS; Markus, D | 1 |
| Cooke, RW; Doyle, J; Rennie, JM | 1 |
2 trial(s) available for ethamsylate and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Prophylaxis of patent ductus arteriosus using ethamsylate in preterms treated with exogenous surfactant.
Topics: Ductus Arteriosus, Patent; Ethamsylate; Female; Gestational Age; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Male; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Severity of Illness Index; Treatment Outcome | 1992 |
Ethamsylate reduces immunoreactive prostacyclin metabolite in low birthweight infants with respiratory distress syndrome.
Topics: 6-Ketoprostaglandin F1 alpha; Benzenesulfonates; Cerebral Hemorrhage; Clinical Trials as Topic; Double-Blind Method; Ethamsylate; Humans; Infant, Low Birth Weight; Infant, Newborn; Respiratory Distress Syndrome, Newborn | 1986 |